Pfizer asks FDA to greenlight COVID-19 booster shots for all adults

The current rules: People who initially received Pfizer or Moderna vaccinations are eligible for a booster six months later if they’re 65 or older, or are at high risk of COVID-19.

published on : 10th November 2021

Taiwan gets first Pfizer-BioNTech vaccines against Covid after long delay

Taiwan had been unable to buy the vaccine itself directly from BioNTech, the German company that had partnered with U.S.-based Pfizer to develop the mRNA vaccine.

published on : 2nd September 2021

Blood clot risk from COVID-19 infection much higher than that after vaccination: Study 

Some of these events have led to restricted use of the Oxford-AstraZeneca vaccine, known as Covishield in India, in a number of countries.

published on : 27th August 2021

Pfizer-BioNtech vaccine set to be first fully approved coronavirus jab 

It has submitted more data to US drug regulator from the late-stage clinical trials and ongoing vaccinations

published on : 23rd August 2021

Vaccine-maker BioNTech sees profits soar in Q2

The company has said the windfall from its mRNA-based coronavirus vaccine will help it to develop drugs against cancer and other diseases.

published on : 9th August 2021

Vaccine maker BioNTech to use mRNA tech to target malaria

The Germany-based company aims to begin clinical trials for a 'safe and highly effective malaria vaccine' by the end of next year.

published on : 26th July 2021

Pfizer/BioNTech to produce Covid-19 vaccine in South Africa

The project will take time to get off the ground however, with the first African-finished vaccines not expected before 2022.

published on : 21st July 2021

COVID-19 vaccine: Pfizer jabs not the best for Delta variant, says Lancet study

People are less likely to develop antibody levels against the B.1.617.2 variant as high as those seen against the previously dominant B.1.1.7 variant.

published on : 5th June 2021

Bahrain offers Pfizer booster for some who got Chinese shots

The mixing of vaccines comes as the Mideast island nation struggles through its worst wave of the virus despite being one of the top countries in the world in per-capita inoculations.

published on : 3rd June 2021

Challenging Covid, India style

The other day, I was chatting with a friend who lives in the US. She was crowing about having gone for her Covid vaccination. Pfizer, she informed me.

published on : 16th May 2021

COVID-19: Vaccine maker BioNTech says no need to waive patents

Ugur Sahin, the chief executive of BioNTech, rejected the US-backed proposal to temporarily lift some intellectual property rights for vaccines in order to boost global supply during the pandemic.

published on : 10th May 2021

Joint venture by Chinese pharmaceutical company and BioNTech SE aims to make 1 billion doses

Shanghai Fosun Pharmaceutical Group Co. said in a stock filing on Sunday night that the companies will invest up to $100 million each to set up the venture.

published on : 10th May 2021

Pfzier and BioNTech to donate COVID-19 vaccines for Olympic athletes

Delivery of doses is set to begin this month to give Olympic delegations time to be fully vaccinated with a second shot before arriving in Tokyo for the games, which open on July 23.

published on : 6th May 2021

Pfizer-BioTech seek vaccine approval for children

The two companies said their submission to the European Medicines Agency was based on an advanced study in more than 2,000 adolescents that showed the vaccine to be safe and effective.

published on : 30th April 2021

The Pfizer/BioNTech Covid vaccine bet that paid off

The downside is that the doses must be kept at ultralow temperatures, though Pfizer has managed to demonstrate that its vaccine can be kept up to two weeks at less intense cold.

published on : 9th April 2021
1 2 >